OPDIVO Trademark

Trademark Overview

On Friday, January 24, 2014, a trademark application was filed for OPDIVO with the United States Patent and Trademark Office. The USPTO has given the OPDIVO trademark a serial number of 86174642. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 19, 2022. This trademark is owned by Bristol-Myers Squibb Company. The OPDIVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of [ obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, ] cancer [, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies ]
opdivo

General Information

Serial Number86174642
Word MarkOPDIVO
Filing DateFriday, January 24, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 19, 2022
Registration Number4914296
Registration DateTuesday, March 8, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Description of MarkThe mark consists of the word "OPDIVO" in stylized font with a diagonal double slash design appearing below the first "O" and above the "V".
Amendment to a Registration/Renewal CertificateIn the statement, Line 4, through line 11, "Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies" is deleted, and Pharmaceutical preparations for human use for the treatment and prevention of cancer is inserted.
Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of [ obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, ] cancer [, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies ]
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 5, 2014
Primary Code005
First Use Anywhere DateMonday, July 6, 2015
First Use In Commerce DateMonday, July 6, 2015

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 19, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 19, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 19, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 28, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, March 8, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 6, 2016AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Monday, May 23, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 22, 2016TEAS SECTION 7 REQUEST RECEIVED
Tuesday, March 8, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, February 3, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 2, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, January 30, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 30, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 27, 2016TEAS EXTENSION RECEIVED
Saturday, August 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 14, 2015NON-FINAL ACTION E-MAILED
Friday, August 14, 2015SU - NON-FINAL ACTION - WRITTEN
Friday, August 14, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, July 27, 2015USE AMENDMENT FILED
Friday, August 14, 2015SOU EXTENSION 1 GRANTED
Monday, July 27, 2015SOU EXTENSION 1 FILED
Friday, August 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 27, 2015TEAS EXTENSION RECEIVED
Monday, July 27, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, January 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 29, 2014ASSIGNED TO LIE
Thursday, October 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 8, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 7, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 1, 2014ASSIGNED TO EXAMINER
Monday, April 7, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, April 7, 2014PRIORITY ACTION E-MAILED
Monday, April 7, 2014PRIORITY ACTION WRITTEN
Wednesday, April 2, 2014ASSIGNED TO EXAMINER
Thursday, February 6, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 28, 2014NEW APPLICATION ENTERED

Related Keywords

opdivo diseases pharmaceutical human anti preparations disorders organ solid auto immune